
IDRSF
Healthcare · Biotechnology · $1.27B market cap
$4.700.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jul 30, 2026 | After the close | -0.23 | -0.53 | -130.1% |
| Feb 26, 2026 | After the close | -0.20 | -0.39 | -96.5% |
| Oct 30, 2025 | After the close | — | -0.50 | — |
| Jul 30, 2025 | After the close | -0.23 | -0.06 | +75.7% |
| May 19, 2025 | Before the open | — | 0.26 | — |
| Feb 5, 2025 | Before the open | — | -0.51 | — |
| Oct 29, 2024 | Before the open | — | -0.53 | — |
| Jul 25, 2024 | Before the open | — | -0.60 | — |
| May 21, 2024 | Before the open | — | 0.15 | — |
| Mar 20, 2024 | Before the open | — | -0.74 | — |
| Feb 6, 2023 | After the close | -1.34 | -1.09 | +18.7% |
| Oct 24, 2022 | After the close | -1.22 | -1.22 | 0.0% |
| Jul 25, 2022 | After the close | -1.24 | -1.24 | 0.0% |
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada. The company has a clinical development pipeline for various therapeutic areas, such as CNS, cardiovascular, immunological disorders, and orphan diseases. It offers QUVIVIQ (daridorexant) for the treatment of…
| Apr 25, 2022 |
| After the close |
| -1.14 |
| -1.12 |
| +1.8% |
| Feb 7, 2022 | After the close | -1.30 | -1.32 | -1.5% |
| Oct 25, 2021 | After the close | -1.06 | -0.83 | +21.7% |
| Jul 26, 2021 | After the close | -0.91 | -0.83 | +8.8% |
| Apr 21, 2021 | After the close | -0.85 | -0.63 | +25.9% |
| Feb 3, 2021 | After the close | -0.90 | -0.85 | +5.6% |
| Oct 26, 2020 | After the close | -0.85 | -0.83 | +2.4% |
| Jul 22, 2020 | After the close | -0.82 | -0.50 | +39.0% |
| Apr 22, 2020 | After the close | -0.86 | -0.90 | -4.7% |
| Feb 5, 2020 | After the close | -1.00 | -1.07 | -7.0% |
| Oct 21, 2019 | After the close | -1.09 | -0.90 | +17.4% |
| Jul 22, 2019 | After the close | -0.99 | -0.95 | +4.0% |
| Apr 17, 2019 | After the close | -0.99 | -0.80 | +19.2% |
| Feb 6, 2019 | After the close | — | -0.82 | — |
| Oct 22, 2018 | After the close | -0.79 | -0.91 | -15.2% |
| Jul 23, 2018 | After the close | -0.80 | -0.68 | +15.0% |
| Apr 18, 2018 | After the close | -0.80 | -0.66 | +17.5% |
| Feb 5, 2018 | After the close | -0.80 | 0.49 | +161.3% |